SCHEDULE 13G

Company

LIGAND PHARMACEUTICALS INC

Filed

February 11, 2008

Accession Number

0000950123-08-001419

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →